Search EN Fareva Foundation Join Fareva News The Group Our Products and services Locations CSR Commitment Contact Contact News Discover Fareva's latest news Innovation and Technologies 10 May 2021 FAREVA INCREASES MANUFACTURING CAPACITY FOR HIGHLY POTENT DRUG PRODUCT MANUFACTURING Read more Corporate 18 January 2021 MSD CLOSES TRANSACTION TO SELL ITS MIRABEL PRODUCTION SITE TO FAREVA PHARMACEUTICAL GROUP Read more Corporate 09 December 2020 CUREVAC AND FAREVA SIGN AGREEMENT FOR FILL & FINISH MANUFACTURING OF CUREVAC’S COVID-19 VACCINE CANDIDATE, CVNCOV Read more Corporate 30 November 2020 FAREVA STRENGTHENS ITS POSITION IN STERILE DEVELOPMENT AND MANUFACTURING Read more Corporate 28 October 2020 FAREVA IS ONE OF THE WORLD LEADERS IN PHARMACEUTICAL SUBCONTRACTING IN THE FIELD OF STERILE PRODUCTS. Read more News, Corporate, Event 25 February 2020 MEET WITH FAREVA AT THE DCAT WEEK IN NYC DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. Read more Select by category Corporate Innovation and Technologies Event DISCOVER FAREVA Who we are History Executive Committee OUR PRODUCTS & SERVICES Pharmaceuticals Cosmetics API Make up Industrial & Homecare LOCATIONS OUR LATEST NEWS Fareva increases manufacturing capacity for highly potent drug product manufacturing MSD closes transaction to sell its Mirabel production site to FAREVA pharmaceutical group CureVac and Fareva sign agreement for fill & finish manufacturing of CureVac’s COVID-19 vaccine candidate, CVNCOV Career Opportunities Contact us Legal Notice Credits Privacy Policy © 2021 Fareva